Negara: Israel
Bahasa: Inggris
Sumber: Ministry of Health
ABIRATERONE ACETATE
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
L02BX03
TABLETS
ABIRATERONE ACETATE 250 MG
PER OS
Required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
ABIRATERONE
Abiraterone Acetate is CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).
2017-06-27
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS )PREPARATIONS( – 1986 The medicine is dispensed with a doctor’s prescription only ABIRATERONE TEVA 250 MG TABLETS EACH TABLET CONTAINS: Abiraterone acetate 250 mg For information on the inactive and allergenic ingredients, see section 2 “Important information about some of the ingredients of the medicine” and section 6 – “Further Information”. READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to the doctor or pharmacist. The medicine is not intended for use in women, children or adolescents. This medicine has been prescribed to treat your ailment. Do not pass it on to others. It may harm them even if it seems to you that their ailment is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? Abiraterone Teva is a prescription medicine containing an active ingredient called abiraterone acetate. Abiraterone Teva, a CYP17 enzyme inhibitor, is given together with prednisone for the treatment of metastatic castration-resistant prostate cancer. Likewise, it is intended for treatment of adult men newly diagnosed with high-risk, metastatic, hormone-sensitive, prostate cancer )mHSPC(, in combination with androgen deprivation therapy )ADT(. THERAPEUTIC GROUP: Specific CYP17 enzyme inhibitor. 2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF: • You are sensitive )allergic( to abiraterone acetate or to any of the additional ingredients contained in the medicine. For the list of the additional ingredients, see section 6 “Further Information”. • You are pregnant or might be pregnant. Abiraterone Teva is not intended for use in women. • You are breastfeeding. • Women who are pregnant or who might be pregnant must not touch Abiraterone Teva without protection. They must take protective measures, such as wearing gloves, if they must touch the medicine. • You are suffering from severe liver function problems. SPECIAL Baca dokumen lengkapnya